Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Ervin-Haynes
A. Ervin-Haynes
Pathology
Monoclonal antibody
Medicine
in patient
Cohort
2
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study of IMC-11F8, a fully human anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in patients with solid tumors. Interim results
2006
Journal of Clinical Oncology
B. Kuenen
E. Witteveen
Rita Ruijter
A. Ervin-Haynes
Manuel Tjin-A-Ton
F. Fox
C. Ding
Giuseppe Giaccone
Emile E. Voest
Show All
Source
Cite
Save
Citations (8)
A PHASE I DOSE-ESCALATION STUDY OF WEEKLY IMC-1121B, A FULLY HUMAN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) IGG1MONOCLONAL ANTIBODY (MAB), IN PATIENTS (PTS) WITH ADVANCED CANCER
2006
Journal of Clinical Oncology
D. R. Camidge
S G Eckhardt
Sami Diab
Lia Gore
Laura Quan Man Chow
Cindy L. O'Bryant
E. Temmer
A. Ervin-Haynes
T. Katz
F. Fox
Roger B. Cohen
Show All
Source
Cite
Save
Citations (29)
1